342 related articles for article (PubMed ID: 38202764)
1. Impact of TRPV1 on Pathogenesis and Therapy of Neurodegenerative Diseases.
Wang W; Sun T
Molecules; 2023 Dec; 29(1):. PubMed ID: 38202764
[TBL] [Abstract][Full Text] [Related]
2. Signaling mechanisms underlying inhibition of neuroinflammation by resveratrol in neurodegenerative diseases.
Huang J; Huang N; Xu S; Luo Y; Li Y; Jin H; Yu C; Shi J; Jin F
J Nutr Biochem; 2021 Feb; 88():108552. PubMed ID: 33220405
[TBL] [Abstract][Full Text] [Related]
3. Natural Products for the Treatment of Neurodegenerative Diseases.
Wang Z; He C; Shi JS
Curr Med Chem; 2020; 27(34):5790-5828. PubMed ID: 31131744
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic Potential of Natural Products in Treating Neurodegenerative Disorders and Their Future Prospects and Challenges.
Rahman MH; Bajgai J; Fadriquela A; Sharma S; Trinh TT; Akter R; Jeong YJ; Goh SH; Kim CS; Lee KJ
Molecules; 2021 Sep; 26(17):. PubMed ID: 34500759
[TBL] [Abstract][Full Text] [Related]
5. Glucagon-like peptide-1 (GLP-1) receptor agonists and neuroinflammation: Implications for neurodegenerative disease treatment.
Kopp KO; Glotfelty EJ; Li Y; Greig NH
Pharmacol Res; 2022 Dec; 186():106550. PubMed ID: 36372278
[TBL] [Abstract][Full Text] [Related]
6. Neuroprotective effect of transient receptor potential Vanilloid 1 agonist capsaicin in Alzheimer's disease model induced with okadaic acid.
Çakır M; Yüksel F; Mustafa Özkut M; Durhan M; Kaymak E; Tekin S; Çiğremiş Y
Int Immunopharmacol; 2023 May; 118():109925. PubMed ID: 37011502
[TBL] [Abstract][Full Text] [Related]
7. Naringenin: A prospective therapeutic agent for Alzheimer's and Parkinson's disease.
Goyal A; Verma A; Dubey N; Raghav J; Agrawal A
J Food Biochem; 2022 Dec; 46(12):e14415. PubMed ID: 36106706
[TBL] [Abstract][Full Text] [Related]
8. Antidiabetic agents as a novel treatment for Alzheimer's and Parkinson's disease.
Nowell J; Blunt E; Gupta D; Edison P
Ageing Res Rev; 2023 Aug; 89():101979. PubMed ID: 37328112
[TBL] [Abstract][Full Text] [Related]
9. Neurodegenerative Disorders of Alzheimer, Parkinsonism, Amyotrophic Lateral Sclerosis and Multiple Sclerosis: An Early Diagnostic Approach for Precision Treatment.
Pathak N; Vimal SK; Tandon I; Agrawal L; Hongyi C; Bhattacharyya S
Metab Brain Dis; 2022 Jan; 37(1):67-104. PubMed ID: 34719771
[TBL] [Abstract][Full Text] [Related]
10. Regulation of Autophagy in Neurodegenerative Diseases by Natural Products.
Liu S; Li X
Adv Exp Med Biol; 2020; 1207():725-730. PubMed ID: 32671789
[TBL] [Abstract][Full Text] [Related]
11. Research on ferroptosis as a therapeutic target for the treatment of neurodegenerative diseases.
Wang Y; Lv MN; Zhao WJ
Ageing Res Rev; 2023 Nov; 91():102035. PubMed ID: 37619619
[TBL] [Abstract][Full Text] [Related]
12. A Novel Treatment Strategy by Natural Products in NLRP3 Inflammasome-Mediated Neuroinflammation in Alzheimer's and Parkinson's Disease.
Lee JH; Kim HJ; Kim JU; Yook TH; Kim KH; Lee JY; Yang G
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33525754
[TBL] [Abstract][Full Text] [Related]
13. [The role of steroid hormones in the neurodegenerative diseases].
Sadowska A; Grzesiak M
Postepy Biochem; 2022 Dec; 68(4):387-398. PubMed ID: 36649137
[TBL] [Abstract][Full Text] [Related]
14. Natural Products from Plants and Algae for Treatment of Alzheimer's Disease: A Review.
Klose J; Griehl C; Roßner S; Schilling S
Biomolecules; 2022 May; 12(5):. PubMed ID: 35625622
[TBL] [Abstract][Full Text] [Related]
15. Exploring the Potential of Aptamers in Targeting Neuroinflammation and Neurodegenerative Disorders: Opportunities and Challenges.
Kong AH; Wu AJ; Ho OK; Leung MM; Huang AS; Yu Y; Zhang G; Lyu A; Li M; Cheung KH
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511539
[TBL] [Abstract][Full Text] [Related]
16. Sirtuins and Their Implications in Neurodegenerative Diseases from a Drug Discovery Perspective.
Yeong KY; Berdigaliyev N; Chang Y
ACS Chem Neurosci; 2020 Dec; 11(24):4073-4091. PubMed ID: 33280374
[TBL] [Abstract][Full Text] [Related]
17. Icariin: A Potential Neuroprotective Agent in Alzheimer's Disease and Parkinson's Disease.
Khezri MR; Ghasemnejad-Berenji M
Neurochem Res; 2022 Oct; 47(10):2954-2962. PubMed ID: 35802286
[TBL] [Abstract][Full Text] [Related]
18. Glycan Mimetics from Natural Products: New Therapeutic Opportunities for Neurodegenerative Disease.
Wang W; Gopal S; Pocock R; Xiao Z
Molecules; 2019 Dec; 24(24):. PubMed ID: 31888221
[TBL] [Abstract][Full Text] [Related]
19. Natural products as a potential modulator of microglial polarization in neurodegenerative diseases.
Jin X; Liu MY; Zhang DF; Zhong X; Du K; Qian P; Gao H; Wei MJ
Pharmacol Res; 2019 Jul; 145():104253. PubMed ID: 31059788
[TBL] [Abstract][Full Text] [Related]
20. Targeting Protein Aggregates with Natural Products: An Optional Strategy for Neurodegenerative Diseases.
Xiang L; Wang Y; Liu S; Liu B; Jin X; Cao X
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
